Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Xu Li

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
ACS Chemical Neuroscience|May 23, 2014
Trace amines and cocaine abuseJun-Xu Li
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2016
Buprenorphine analogue BU08028 is one step closer to the Holy Grail of opioid researchJun-Xu Li
Behavioural Brain Research|May 7, 2014
Pain and depression comorbidity: a preclinical perspectiveJun-Xu Li
Advances in Pharmacology (San Diego, Calif.)|March 28, 2022
PrefaceJun-Xu Li
Pharmacology & Therapeutics|March 22, 2017
Imidazoline I<sub>2</sub> receptors: An updateJun-Xu Li
European Journal of Pharmacology|March 19, 2013
The application of conditioning paradigms in the measurement of painJun-Xu Li
Neuropharmacology|April 29, 2019
Combining opioids and non-opioids for pain management: Current statusJun-Xu Li
European Journal of Pharmacology|March 5, 2011
Imidazoline I2 receptors: target for new analgesics?Jun-Xu Li, Yanan Zhang
CNS Drugs|November 12, 2021
Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use DisordersRuyan Wu, Jun-Xu Li
European Journal of Pharmacology|June 21, 2015
Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addictionLi Jing, Jun-Xu Li
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
ACS Chemical Neuroscience|May 23, 2014
Trace amines and cocaine abuseJun-Xu Li
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2016
Buprenorphine analogue BU08028 is one step closer to the Holy Grail of opioid researchJun-Xu Li
Behavioural Brain Research|May 7, 2014
Pain and depression comorbidity: a preclinical perspectiveJun-Xu Li
Advances in Pharmacology (San Diego, Calif.)|March 28, 2022
PrefaceJun-Xu Li
Pharmacology & Therapeutics|March 22, 2017
Imidazoline I<sub>2</sub> receptors: An updateJun-Xu Li
European Journal of Pharmacology|March 19, 2013
The application of conditioning paradigms in the measurement of painJun-Xu Li
Neuropharmacology|April 29, 2019
Combining opioids and non-opioids for pain management: Current statusJun-Xu Li
European Journal of Pharmacology|March 5, 2011
Imidazoline I2 receptors: target for new analgesics?Jun-Xu Li, Yanan Zhang
CNS Drugs|November 12, 2021
Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use DisordersRuyan Wu, Jun-Xu Li
European Journal of Pharmacology|June 21, 2015
Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addictionLi Jing, Jun-Xu Li
Pageof 15